Escape Bio nabs $73m
Escape Bio, a developer of treatments for genetic neurodegenerative diseases, has raised $73 million in financing.
Escape Bio, a developer of treatments for genetic neurodegenerative diseases, has raised $73 million in financing.
Copyright PEI Media
Not for publication, email or dissemination